Related references
Note: Only part of the references are listed.Blocking Tumor Necrosis Factor a Enhances CD8 T-cell-Dependent Immunity in Experimental Melanoma
Florie Bertrand et al.
CANCER RESEARCH (2015)
CD4+ T Cell Help Selectively Enhances High-Avidity Tumor Antigen-Specific CD8+ T Cells
Ziqiang Zhu et al.
JOURNAL OF IMMUNOLOGY (2015)
Targeting the PD-1 pathway: a promising future for the treatment of melanoma
Andrew Mamalis et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2014)
Interleukin 12: still a promising candidate for tumor immunotherapy?
Witold Lasek et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
From the discovery of monoclonal antibodies to their therapeutic application: An historical reappraisal
Domenico Ribatti
IMMUNOLOGY LETTERS (2014)
The current spectrum of infection in cancer patients with chemotherapy related neutropenia
Lior Nesher et al.
INFECTION (2014)
Clinical use of dendritic cells for cancer therapy
Sebastien Anguille et al.
LANCET ONCOLOGY (2014)
Quinoline-3-Carboxamides Modulate Primary T Cell-Dependent B Cell Responses but do not Inhibit Functional Immunity
E. Kallberg et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2014)
High-dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma: A Contemporary Experience
Michael Hanzly et al.
UROLOGY (2014)
PSP activates monocytes in resting human peripheral blood mononuclear cells: Immunomodulatory implications for cancer treatment
Bhagwant Kaur Sekhon et al.
FOOD CHEMISTRY (2013)
Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant
Abbi L. Engel et al.
IMMUNOBIOLOGY (2013)
Dendritic Cell-Derived Exosomes Need To Activate Both T and B Cells To Induce Antitumor Immunity
Tanja I. Naslund et al.
JOURNAL OF IMMUNOLOGY (2013)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
Anti-malarial effect of gum arabic
Adil Ballal et al.
MALARIA JOURNAL (2011)
The Known Immunologically Active Components of Astragalus Account for Only a Small Proportion of the Immunological Adjuvant Activity When Combined with Conjugate Vaccines
Feng Hong et al.
PLANTA MEDICA (2011)
Clonal expansions of cytotoxic T cells exist in the blood of patients with Waldenstrom macroglobulinemia but exhibit anergic properties and are eliminated by nucleoside analogue therapy
Jia Li et al.
BLOOD (2010)
Stimulation of Mouse Dendritic Cells by Gum Arabic
Nguyen Thi Xuan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2010)
Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma
Ross D. Brown et al.
LEUKEMIA & LYMPHOMA (2009)
Evaluation of widely consumed botanicals as immunological adjuvants
Govind Ragupathi et al.
VACCINE (2008)
A ninety-day oral toxicity study of a new type of processed gum arabic, from Acacia tree (Acacia senegal) exudates, in F344 rats
Y Doi et al.
FOOD AND CHEMICAL TOXICOLOGY (2006)
The culture duration affects the immunomodulatory and anticancer effect of polysaccharopeptide derived from Coriolus versicolor
CL Lee et al.
ENZYME AND MICROBIAL TECHNOLOGY (2006)
The use of thalidomide in myeloma therapy as an effective anticancer drug
Daniel M. -Y. Sze et al.
CURRENT CANCER DRUG TARGETS (2006)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Polysaccharopeptides of Coriolus versicolor:: physiological activity, uses, and production
T Cui et al.
BIOTECHNOLOGY ADVANCES (2003)
Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival
DMY Sze et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
